These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8384365)

  • 1. Preparation of heptakis(2,6-di-O-ethyl)-beta-cyclodextrin and its nuclear magnetic resonance spectroscopic characterization.
    Hirayama F; Kurihara M; Horiuchi Y; Utsuki T; Uekama K; Yamasaki M
    Pharm Res; 1993 Feb; 10(2):208-13. PubMed ID: 8384365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activity.
    Hirayama F; Mieda S; Miyamoto Y; Arima H; Uekama K
    J Pharm Sci; 1999 Oct; 88(10):970-5. PubMed ID: 10514341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin: interaction and dissolution properties.
    Yamada T; Imai T; Ouchi K; Otagiri M; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1264-9. PubMed ID: 10993223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrins in aqueous solution.
    Miyake K; Hirayama F; Uekama K
    J Pharm Sci; 1999 Jan; 88(1):39-45. PubMed ID: 9874700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid-state 13C nuclear magnetic resonance spectroscopic study on amorphous solid complexes of tolbutamide with 2-hydroxypropyl-alpha- and -beta-cyclodextrins.
    Kimura K; Hirayama F; Arima H; Uekama K
    Pharm Res; 1999 Nov; 16(11):1729-34. PubMed ID: 10571279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the interaction of clobazam with cyclodextrins in solution and in the solid state.
    Nakai Y; el-Said Aboutaleb A; Yamamoto K; Saleh SI; Ahmed MO
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):728-32. PubMed ID: 2347015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chiral discrimination of phenethylamines with beta-cyclodextrin and heptakis(2,3-di-O-acetyl)beta-cyclodextrin by capillary electrophoresis and NMR spectroscopy.
    Branch SK; Holzgrabe U; Jefferies TM; Mallwitz H; Matchett MW
    J Pharm Biomed Anal; 1994 Dec; 12(12):1507-17. PubMed ID: 7696375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclodextrins as carriers for kavalactones in aqueous media: spectroscopic characterization of (S)-7,8-dihydrokavain and beta-cyclodextrin inclusion complex.
    Pescitelli G; Bilia AR; Bergonzi MC; Vincieri FF; Di Bari L
    J Pharm Biomed Anal; 2010 Aug; 52(4):479-83. PubMed ID: 20185265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study on inclusion complexation of maltosyl-beta-cyclodextrin, heptakis(2,6-di-O-methyl)-beta-cyclodextrin and beta-cyclodextrin with fucosterol in aqueous and solid state.
    Acartürk F; Imai T; Saito H; Ishikawa M; Otagiri M
    J Pharm Pharmacol; 1993 Dec; 45(12):1028-32. PubMed ID: 7908969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells.
    Motoyama K; Kameyama K; Onodera R; Araki N; Hirayama F; Uekama K; Arima H
    Eur J Pharm Sci; 2009 Oct; 38(3):249-61. PubMed ID: 19664706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development and pharmaceutical evaluation of hydrophobic cyclodextrin derivatives as modified-release drug carriers].
    Hirayama F
    Yakugaku Zasshi; 1993 Jun; 113(6):425-37. PubMed ID: 8355145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilizing and solubilizing effects of sulfobutyl ether beta-cyclodextrin on prostaglandin E1 analogue.
    Uekama K; Hieda Y; Hirayama F; Arima H; Sudoh M; Yagi A; Terashima H
    Pharm Res; 2001 Nov; 18(11):1578-85. PubMed ID: 11758766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR spectroscopic investigation of inclusion complexes between cyclodextrins and the neurotoxin tetramethylenedisulfotetramine.
    Mayer BP; Albo RL; Hok S; Valdez CA
    Magn Reson Chem; 2012 Mar; 50(3):229-35. PubMed ID: 22383439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible enhancing mechanism of the cutaneous permeation of 4-biphenylylacetic acid by beta-cyclodextrin derivatives in hydrophilic ointment.
    Arima H; Miyaji T; Irie T; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):582-6. PubMed ID: 8882455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of heptakis (2,3,6-tri-O-methyl)-beta-cyclodextrin with cholesterol in aqueous solution.
    Nishijo J; Moriyama S; Shiota S; Kamigauchi M; Sugiura M
    Chem Pharm Bull (Tokyo); 2004 Dec; 52(12):1405-10. PubMed ID: 15577234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.
    Arima H; Yunomae K; Miyake K; Irie T; Hirayama F; Uekama K
    J Pharm Sci; 2001 Jun; 90(6):690-701. PubMed ID: 11357172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced rectal absorption and reduced local irritation of the anti-inflammatory drug ethyl 4-biphenylylacetate in rats by complexation with water-soluble beta-cyclodextrin derivatives and formulation as oleaginous suppository.
    Arima H; Kondo T; Irie T; Uekama K
    J Pharm Sci; 1992 Nov; 81(11):1119-25. PubMed ID: 1447717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative enantioseparation of ketoprofen with trimethylated α-, β-, and γ-cyclodextrins in capillary electrophoresis and study of related selector-selectand interactions using nuclear magnetic resonance spectroscopy.
    Samakashvili S; Salgado A; Scriba GK; Chankvetadze B
    Chirality; 2013 Feb; 25(2):79-88. PubMed ID: 23255364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prominent inclusion effect of dimethyl-beta-cyclodextrin on photoisomerization of the thromboxane synthetase inhibitor (E)-4-(1-imidazoylmethyl)cinnamic acid.
    Hirayama F; Utsuki T; Uekama K; Yamasaki M; Harata K
    J Pharm Sci; 1992 Aug; 81(8):817-22. PubMed ID: 1403730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR study of solid C60(gamma-cyclodextrin)2.
    Tseng WY; Chen YH; Khairullin II; Cheng S; Hwang LP
    Solid State Nucl Magn Reson; 1997 Aug; 8(4):219-29. PubMed ID: 9373902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.